ROP Q1 2026 Earnings EPS Beat Driven by Operational Strength Amid Modest Market Response TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty ASP Isotopes Q4 2025 Earnings Widerthanexpected loss fails to dampen investor sentiment RDNW Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue NonDisclosure PRIM Q1 2026 Earnings EPS Misses Estimate by 315 Stock Still Climbs 69 Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline